Review of antimicrobial use and considerations in the elderly population

Angela Giarratano,1 Samantha EL Green,1 David P Nicolau2 1Department of Pharmacy, Hartford Hospital, Hartford, CT, USA; 2Center for Anti-Infective Research and Development, Hartford Hospital, Hartford, CT, USA Abstract: Pharmacologic management of infections in elderly patients presents multiple c...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Giarratano A, Green SEL, Nicolau DP
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2018
Materias:
age
Acceso en línea:https://doaj.org/article/235e9f1acf894153adbbe5a5fb200d97
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:235e9f1acf894153adbbe5a5fb200d97
record_format dspace
spelling oai:doaj.org-article:235e9f1acf894153adbbe5a5fb200d972021-12-02T07:38:51ZReview of antimicrobial use and considerations in the elderly population1178-1998https://doaj.org/article/235e9f1acf894153adbbe5a5fb200d972018-04-01T00:00:00Zhttps://www.dovepress.com/review-of-antimicrobial-use-and-considerations-in-the-elderly-populati-peer-reviewed-article-CIAhttps://doaj.org/toc/1178-1998Angela Giarratano,1 Samantha EL Green,1 David P Nicolau2 1Department of Pharmacy, Hartford Hospital, Hartford, CT, USA; 2Center for Anti-Infective Research and Development, Hartford Hospital, Hartford, CT, USA Abstract: Pharmacologic management of infections in elderly patients presents multiple challenges to health care professionals due to variable pharmacokinetics, pharmacodynamics, and immune function. Age is a well-established risk factor for infection, but furthermore is a risk factor for prolonged length of hospital stay, increased incidence of complications, and significant and sustained decline in baseline functional status. In 2014, 46.2 million Americans were aged ≥65 years, accounting for 14.5% of the total population. By 2033, for the first time, the population of persons aged ≥65 years is projected to outnumber the people <18 years of age. According to the National Ambulatory Medical Care Survey and the National Hospital Ambulatory Medical Care Survey, 154 million prescriptions for antimicrobials were estimated to have been written in doctors’ offices and emergency departments during a 1-year time period. In 2014, 266.1 million courses of antimicrobials were dispensed to outpatients by US community pharmacies. A study that evaluated 2007–2009 Medicare Part D data found that patients aged ≥65 years used more antimicrobials, at 1.10 per person per year, compared to 0.88 antimicrobials used per person per year in patients aged 0–64 years. With the abundance of antimicrobial prescriptions and the current growth in the number and proportion of older adults in the US, it is essential that health care providers understand appropriate antimicrobial pharmacotherapy in the elderly patient. This review focuses on the use and implications of antimicrobial agents in the elderly population. Keywords: infection, age, drug resistance, bacterialGiarratano AGreen SELNicolau DPDove Medical Pressarticleinfectionagedrug resistancepharmacokineticbacterialantimicrobialGeriatricsRC952-954.6ENClinical Interventions in Aging, Vol Volume 13, Pp 657-667 (2018)
institution DOAJ
collection DOAJ
language EN
topic infection
age
drug resistance
pharmacokinetic
bacterial
antimicrobial
Geriatrics
RC952-954.6
spellingShingle infection
age
drug resistance
pharmacokinetic
bacterial
antimicrobial
Geriatrics
RC952-954.6
Giarratano A
Green SEL
Nicolau DP
Review of antimicrobial use and considerations in the elderly population
description Angela Giarratano,1 Samantha EL Green,1 David P Nicolau2 1Department of Pharmacy, Hartford Hospital, Hartford, CT, USA; 2Center for Anti-Infective Research and Development, Hartford Hospital, Hartford, CT, USA Abstract: Pharmacologic management of infections in elderly patients presents multiple challenges to health care professionals due to variable pharmacokinetics, pharmacodynamics, and immune function. Age is a well-established risk factor for infection, but furthermore is a risk factor for prolonged length of hospital stay, increased incidence of complications, and significant and sustained decline in baseline functional status. In 2014, 46.2 million Americans were aged ≥65 years, accounting for 14.5% of the total population. By 2033, for the first time, the population of persons aged ≥65 years is projected to outnumber the people <18 years of age. According to the National Ambulatory Medical Care Survey and the National Hospital Ambulatory Medical Care Survey, 154 million prescriptions for antimicrobials were estimated to have been written in doctors’ offices and emergency departments during a 1-year time period. In 2014, 266.1 million courses of antimicrobials were dispensed to outpatients by US community pharmacies. A study that evaluated 2007–2009 Medicare Part D data found that patients aged ≥65 years used more antimicrobials, at 1.10 per person per year, compared to 0.88 antimicrobials used per person per year in patients aged 0–64 years. With the abundance of antimicrobial prescriptions and the current growth in the number and proportion of older adults in the US, it is essential that health care providers understand appropriate antimicrobial pharmacotherapy in the elderly patient. This review focuses on the use and implications of antimicrobial agents in the elderly population. Keywords: infection, age, drug resistance, bacterial
format article
author Giarratano A
Green SEL
Nicolau DP
author_facet Giarratano A
Green SEL
Nicolau DP
author_sort Giarratano A
title Review of antimicrobial use and considerations in the elderly population
title_short Review of antimicrobial use and considerations in the elderly population
title_full Review of antimicrobial use and considerations in the elderly population
title_fullStr Review of antimicrobial use and considerations in the elderly population
title_full_unstemmed Review of antimicrobial use and considerations in the elderly population
title_sort review of antimicrobial use and considerations in the elderly population
publisher Dove Medical Press
publishDate 2018
url https://doaj.org/article/235e9f1acf894153adbbe5a5fb200d97
work_keys_str_mv AT giarratanoa reviewofantimicrobialuseandconsiderationsintheelderlypopulation
AT greensel reviewofantimicrobialuseandconsiderationsintheelderlypopulation
AT nicolaudp reviewofantimicrobialuseandconsiderationsintheelderlypopulation
_version_ 1718399269275172864